Lv2
120 积分 2025-05-30 加入
Abstract PO-076: Murine adapted FOLFIRINOX for standard-of-care in KPC mice
9小时前
求助中
Efficacy and safety of gemcitabine/nab-paclitaxel combined with anlotinib and PD-1 inhibitors as a first-line treatment for advanced pancreatic cancer
2个月前
已完结
Double Peaking Phenomena in Pharmacokinetic Disposition Revisited
3个月前
已完结
Non-regulated LC–MS/MS bioanalysis in support of early drug development: a Novartis perspective
4个月前
已完结
N-Oxide reduction by hemoglobin, cytochrome C and ferrous ions
4个月前
已关闭
Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration
4个月前
已完结
Metabolism of new drug modalities research advances – 2024 year in review
4个月前
已完结
Drug Targeting Towards the Lymphatics
4个月前
已完结
Drug Targeting Towards the Lymphatics
4个月前
已关闭
Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders
5个月前
已完结
皖公网安备34019202002308
